If we use these drugs without changing our lifestyle, we accomplish absolutely nothing, Juan Jose Gorgojo, the director of nutrition services at the Fundacin Alcorcn University Hospital, said to EL PAS
Alteration of Reward Pathways : GLP-1 receptors are involved in the brains reward pathways, which are also engaged by alcohol consumption
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
For prescription fills exceeding 30 days, we assumed supply extended across subsequent months (e.g., a 60-day fill was counted as two months of supply), referred to as active supply. Patients were required to have at least two consecutive months of active supply
If you are overweight with a weight-related health condition or have a BMI of 30 or greater, prescription weight loss injections may be right for you
Some recovery may be possible in the first few months
